Answers are grounded in this paper and cite their sources.
Heterologous reinfection study shows infection-induced immunity reduces lung lesions in macaques, suggesting vaccines may work broadly.
Immunological memory elicited either through previous or ongoing M. tuberculosis (Mtb) infection provides a critical mechanism by which hosts protect against re-infection and disease progression upon Mtb re-exposure. Conversely, the global circulation of—and uneven competition between—distinct Mtb strains suggest certain bacterial clades have enhanced ability to spread across communities, potentially by evading memory responses gained by prior infection with genomically different strains. To address whether memory responses induced by one strain can protect against a genetically distinct strain, we conducted a heterologous reinfection study in cynomolgus macaques involving primary infection by a Lineage 4 Erdman Mtb strain and subsequent re-challenge by a Lineage 2 strain (HT-L2). HT-L2 belongs to a clade that epidemiology showed to be spreading successfully over the last decade in Lima, Peru. Here, through microbiologic, PET-CT imaging and sequencing of Mtb genomic barcodes, we show that reinfected animals developed fewer lung lesions and controlled both pulmonary and disseminated forms of disease better than naïve animals that have had no prior exposure to Mtb. Thus, protection against reinfection is not limited by Mtb lineage, providing optimism that vaccines can be effective across populations and geographic locations.
No takes yet. Share an insight, caveat, or question.
Simonson et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: